Anthony E. Mega
Impact in
Papers in
-
- Renal cell carcinoma treatment 7
- Prostate Cancer Treatment and Research 7
- Prostate Cancer Diagnosis and Treatment 5
- Surgery 11
- Bladder and Urothelial Cancer Treatments 11
- Co-authors
- Howard P. Safran (5 shared papers)James Gulley (1 shared paper)Thomas E. Stinchcombe (1 shared paper)Karen L. Kelly (1 shared paper)Carolyn D. Britten (1 shared paper)Alain Ravaud (1 shared paper)Ani Sarkis Balmanoukian (1 shared paper)Jeffrey R. Infante (1 shared paper)
- Journals
- American Journal of Hematology (4 papers)Urologic Oncology Seminars and Original Investigations (3 papers)The Lancet Oncology (2 papers)Prostate Cancer and Prostatic Diseases (2 papers)Journal of Cancer Policy (2 papers)
- Partner nations
- United StatesKenyaNetherlands
In The Last Decade
Anthony E. Mega
50 papers receiving 2k citations
Anthony E. Mega's Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 528
- Surgery 742
- Pulmonary and Respiratory Medicine 400
- Endocrine and Autonomic Systems 45
- Radiology, Nuclear Medicine and Imaging 95
Countries citing papers authored by Anthony E. Mega
This map shows the geographic impact of Anthony E. Mega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony E. Mega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony E. Mega more than expected).
Fields of papers citing papers by Anthony E. Mega
This network shows the impact of papers produced by Anthony E. Mega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony E. Mega. The network helps show where Anthony E. Mega may publish in the future.
Co-authors
The 25 scholars most cited alongside Anthony E. Mega, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study Hit paper breakdown → | 2017 | 512 |
| 2 | Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2021 | 490 |
| 3 | 2019 | 142 | |
| 4 | 2019 | 79 | |
| 5 | 2009 | 64 | |
| 6 | 2020 | 63 | |
| 7 | 2015 | 58 | |
| 8 | 1989 | 53 | |
| 9 | 2009 | 48 | |
| 10 | 2013 | 40 | |
| 11 | 2018 | 35 | |
| 12 | 1999 | 34 | |
| 13 | 2022 | 33 | |
| 14 | 2005 | 29 | |
| 15 | 2011 | 28 | |
| 16 | 2015 | 27 | |
| 17 | 2017 | 24 | |
| 18 | 1997 | 22 | |
| 19 | 2001 | 22 | |
| 20 | 2006 | 22 |
About Anthony E. Mega
Anthony E. Mega is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Hematology, having authored 52 papers that have together received 2.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (11 papers), Renal cell carcinoma treatment (7 papers), Prostate Cancer Treatment and Research (7 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Innovations in Medical Education (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Patient-Provider Communication in Healthcare (3 papers) and Parvovirus B19 Infection Studies (2 papers). The work is most often cited by research in Oncology (528 citations), Surgery (742 citations), Pulmonary and Respiratory Medicine (400 citations), Endocrine and Autonomic Systems (45 citations) and Radiology, Nuclear Medicine and Imaging (95 citations). Anthony E. Mega has collaborated with scholars based in United States, Kenya and Netherlands. Frequent co-authors include Howard P. Safran, James Gulley, Thomas E. Stinchcombe, Karen L. Kelly, Carolyn D. Britten, Alain Ravaud, Ani Sarkis Balmanoukian, Jeffrey R. Infante, Ding Wang and Michael Schlichting. Their work appears in journals such as American Journal of Hematology, Urologic Oncology Seminars and Original Investigations, The Lancet Oncology, Prostate Cancer and Prostatic Diseases and Journal of Cancer Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.